176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-7.52%
Both yoy net incomes decline, with TSM at -32.10%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.02%
Some D&A expansion while TSM is negative at -18.13%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-133.25%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
2742.05%
SBC growth of 2742.05% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-203.72%
Both reduce yoy usage, with TSM at -91.73%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
9.47%
AR growth while TSM is negative at -100.00%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-392.66%
Negative yoy inventory while TSM is 100.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
4015.99%
AP growth well above TSM's 100.00%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-176.67%
Both reduce yoy usage, with TSM at -94.48%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-29.49%
Both negative yoy, with TSM at -108.36%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-77.64%
Both yoy CFO lines are negative, with TSM at -34.74%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
11.85%
Lower CapEx growth vs. TSM's 25.37%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-452.52%
Negative yoy acquisition while TSM stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
40.63%
Purchases well above TSM's 63.99%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-87.51%
Both yoy lines are negative, with TSM at -45.72%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-452.52%
Both yoy lines negative, with TSM at -11.05%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-1371.68%
We reduce yoy invests while TSM stands at 55.36%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
288.99%
We slightly raise equity while TSM is negative at -12.18%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.